(Q71844238)

English

An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models

scientific article published on 01 May 1995

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

pharmacokinetics

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

M G Rosenblum

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

L Cheung

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J L Murray

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 May 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

40

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

322-328

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoconjugates in drug delivery systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macroscopic and microscopic early effects of tumour necrosis factor on murine Meth A sarcoma, and relation to curative activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of recombinant tumor necrosis factor in cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotoxins containing single-chain ribosome-inactivating proteins.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of human recombinant tumor necrosis factor-alpha antiproliferative effects on human cells in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor alpha and gamma-interferon enhancement of anti-epidermal growth factor receptor monoclonal antibody binding to human melanoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale for clinical use of immunotoxins in cancer and autoimmune disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of natural interferon alpha conjugated to a monoclonal antibody anti mammary epithelial mucin (Mc5) for the treatment of human breast cancer xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Construction and expression of antibody-tumor necrosis factor fusion proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modification of TNF-alpha pharmacokinetics in SA-1 tumor-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody-mediated delivery of tumor necrosis factor (TNF-alpha): improvement of cytotoxicity and reduction of cellular resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Murine anti-human IL-6 monoclonal antibody prolongs the half-life in circulating blood and thus prolongs the bioactivity of human IL-6 in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiviral and Antiproliferative Effects of Interferons Delivered via Monoclonal Antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo regulation of tumor antigen expression by human recombinant interferons

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of genetically engineered immunoconjugates of lymphotoxin and a chimeric anti-ganglioside GD2 antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human tumor necrosis factor. Production, purification, and characterization

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of immunotoxins active against ovarian cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A gelonin-containing immunotoxin directed against human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-induced changes in pharmacokinetics and tumor uptake of 111In-labeled antimelanoma antibody 96.5 in melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies and immunoconjugates for cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of the cytotoxic effect of tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/7600565

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01519633

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7600565%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71844238&oldid=2219335204"